Emcure Pharmaceuticals Ltd Share Price
(EMCURE)
₹983.4▲1.85%
as on 03:04PM, 06 Mar 2025
Emcure Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹971.3Day's Price Range₹99952 Week's Low
52 Week's High
₹935.2552-Week Price Range₹1,580
| Returns % | |
| 1 Month Return | -24.88 % |
| 3 Month Return | -29.47 % |
| 1 Year Return | -28.96 % |
| Market Stats | |
| Previous Close | ₹965.50 |
| Open | ₹983.35 |
| Volume | 63.75K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹18,289.64Cr |
Emcure Pharmaceuticals Ltd Key Statistics
P/E Ratio
29.56
PEG Ratio
2.58
Market Cap
₹18,289.64 Cr
P/B Ratio
0EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
8.52
Emcure Pharmaceuticals Ltd Mutual Fund Holdings
Emcure Pharmaceuticals Ltd Analyst Rating
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Emcure Pharmaceuticals Ltd. An average target of ₹1591.67
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Share analysis
Emcure Pharmaceuticals Ltd price forecast by 3 analysts
Upside of64.85%
High
₹1685
Target
₹1591.67
Low
₹1440
Emcure Pharmaceuticals Ltd target price ₹1591.67, a slight upside of 64.85% compared to current price of ₹983.4. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Emcure Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Emcure Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Receives USFDA Observations - 26 Feb, 2025
Emcure Pharmaceuticals announced that its API manufacturing facility received two observations from the USFDA following an inspection. The company is addressing these observations and will respond within the required timeframe.Clarification on Executive Role at Emcure Pharmaceuticals - 08 Feb, 2025
Emcure Pharmaceuticals clarified that the individual mentioned in the profile is the Whole-time Director, not the Executive Director and CEO of its India Business.Emcure Pharmaceuticals Reports Strong Q3 Growth - 06 Feb, 2025
Emcure Pharmaceuticals reported a 35.4% increase in Q3FY25 profit to Rs 153.7 crore, with revenue rising 17.6% to Rs 1,962.6 crore. Despite a tax demand, shares rose 3.6% following the positive results, highlighting strong international business performance.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 15.05% to 15.14% in Dec 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 2.91% to 3.05% in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 1 month, EMCURE stock has moved down by -24.9%
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 78.08% to 77.94% in Dec 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.30% to 3.10% in Dec 2024 quarter
Emcure Pharmaceuticals Ltd Financials
Index Inclusions
Emcure Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 77.94% | ||
| Foreign Institutions | 3.05% | 4.85 | |
| Mutual Funds | 3.1% | ||
| Retail Investors | 15.14% | 0.61 | |
| Others | 0.77% | 16.61 |
Emcure Pharmaceuticals Ltd Key Indicators
Emcure Pharmaceuticals Ltd Valuation
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (28.97x)
March 4, 2025
Today (29.56x)
March 5, 2025
Industry (49.60x)
March 5, 2025
Highest (53.98x)
September 18, 2024
Emcure Pharmaceuticals Ltd Earnings and Dividends
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 35.5% since last year same period to ₹153.72Cr in the Q3 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -21% fall in its net profits since last 3-months.
Read More about Earnings Results
Emcure Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Emcure Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Emcure Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹18,289.64 Cr | -5.79% | 0.73 | ₹527 Cr | ₹6,658 Cr | |
| NA | ₹98.00 Cr | -0.95% | 0.78 | NA | NA | |
| NA | ₹52.57 Cr | 143.63% | 0.75 | NA | NA | |
| NA | ₹112.16 Cr | -3.19% | 0.00 | ₹3 Cr | ₹103 Cr | |
| NA | ₹249.31 Cr | 266.19% | 0.58 | -₹12 Cr | ₹15 Cr |
About Emcure Pharmaceuticals Ltd
Share Price: ₹983.40 per share as on 06 Mar, 2025 03:04 PM
Market Capitalisation: ₹18,289.64Cr as of today
Revenue: ₹1,962.63Cr as on December 2024 (Q4 24)
Net Profit: ₹156.09Cr as on December 2024 (Q4 24)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Emcure Pharmaceuticals Ltd
What is Emcure Pharmaceuticals Ltd price today?
Emcure Pharmaceuticals Ltd share price today stands at ₹983.4, Open: ₹983.35, Previous Close: ₹965.5, High: ₹999, Low: ₹971.3, 52 Week High: ₹1580, 52 Week Low: ₹935.25.
How to Buy Emcure Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Emcure Pharmaceuticals Ltd shares
Is Emcure Pharmaceuticals Ltd listed on NSE?
Emcure Pharmaceuticals Ltd is listed on NSE
Is Emcure Pharmaceuticals Ltd listed on BSE?
Emcure Pharmaceuticals Ltd is listed on BSE
What are today's High and Low prices of Emcure Pharmaceuticals Ltd?
- Today's highest price of Emcure Pharmaceuticals Ltd is ₹999.
- Today's lowest price of Emcure Pharmaceuticals Ltd is ₹971.3.
What are today's traded volumes of Emcure Pharmaceuticals Ltd?
Today's traded volume of Emcure Pharmaceuticals Ltd(EMCURE) is 63.75K.
What is today's market capitalisation of Emcure Pharmaceuticals Ltd?
Today's market capitalisation of Emcure Pharmaceuticals Ltd(EMCURE) is ₹18289.64Cr.
What is the 52 Week High and Low Range of Emcure Pharmaceuticals Ltd?
How much percentage Emcure Pharmaceuticals Ltd is down from its 52 Week High?
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹983.4. It is down -37.76% from its 52 Week High price of ₹1580
How much percentage Emcure Pharmaceuticals Ltd is up from its 52 Week low?
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹983.4. It is up 5.15% from its 52 Week Low price of ₹935.25
What are the historical returns of Emcure Pharmaceuticals Ltd?
What is the PE ratio of Emcure Pharmaceuticals Ltd today?
PE Ratio of Emcure Pharmaceuticals Ltd is 29.56
PE ratio = Emcure Pharmaceuticals Ltd Market price per share / Emcure Pharmaceuticals Ltd Earnings per share